Merapi Utama Pharma

What Merapi Utama Pharma does

PT Merapi Utama Pharma is a privately-held Indonesian distributor of pharmaceutical and healthcare products, headquartered in Jakarta and operating under the merapi.net domain. The firm was founded in 1973, giving it more than fifty years of continuous operating history in the Indonesian pharmaceutical supply chain. It is a for-profit entity that has remained unlisted, and it operates with a small headcount in the 11–50 employee band, indicating a focused, niche-scale distribution operation rather than a large national wholesaler.

The company's core activity is the procurement and onward distribution of pharmaceutical and healthcare products to downstream healthcare buyers; however, the available source material provides no detail on its specific product portfolio, principal supplier relationships, customer mix, distribution footprint, logistics infrastructure, or technology stack. No products, services, partnerships, certifications, management team members, or technology platforms are disclosed, and the company's own website returns only a loading/verification page with no substantive content.

As a result, the revenue model cannot be characterized beyond the general mechanics of a pharma distributor (margin on physical product movement, typically through wholesale or specialty channels), and no pricing model, go-to-motion, or customer segmentation is documented. The information available supports a minimal fact-base: a long-tenured, small, privately-held Indonesian pharma distributor in Jakarta, with material gaps in operational, financial, and commercial detail that any investment-grade analysis would need to resolve through primary diligence.

Name

Merapi Utama Pharma

Legal name

Merapi Utama Pharma

Website

https://merapi.net

Company type

Private

Founded year

1973

Headcount range

11–50 employees

Short description

PT Merapi Utama Pharma is a privately-held Indonesian pharmaceutical and healthcare product distributor headquartered in Jakarta, founded in 1973 and operating with a small 11–50 person team serving downstream healthcare buyers.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Pharmaceutical distribution
• Healthcare product supply
• Pharmaceutical wholesaling
• Medical product distribution
• Pharmaceutical supply chain

Headquarters

HQ city

Jakarta

HQ country

Indonesia

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales

Core offering

PT Merapi Utama Pharma is a distributor of pharmaceutical and healthcare products based in Jakarta, Indonesia. The company supplies pharmaceutical and healthcare items to downstream customers in the Indonesian market, operating as a domestic wholesaler/distributor rather than a manufacturer.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical and healthcare product distribution

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• PT Kimia Farma Trading & Distribution: Distribution arm of Indonesia's largest state-owned pharmaceutical enterprise, wholesaling drugs and medical products nationwide. Directly comparable to Merapi Utama Pharma as a Jakarta-based pharma distributor serving institutional and retail customers.
• PT Indofarma: State-owned pharmaceutical manufacturer and distributor in Indonesia with nationwide reach. Overlaps directly with Merapi Utama Pharma on distribution of pharmaceutical and healthcare products to hospitals, pharmacies, and government programs.
• PT Enseval Putera Megatrading: Indonesia's largest pharmaceutical and consumer goods distributor, listed on IDX. Closely comparable business model—bulk pharma distribution to pharmacies, hospitals, and institutions across Indonesia—making it the most relevant scale benchmark.
• PT Anugrah Argon Medica: Indonesian pharmaceutical and medical-device distribution company serving hospitals, clinics, and pharmacies nationwide. Directly comparable to Merapi Utama Pharma's core pharma wholesaling activity in Jakarta and across Indonesia.
• PT Mensa Binasukses: Indonesian distributor of pharmaceutical, medical device, and consumer healthcare products with national reach. Comparable product mix and customer base to Merapi Utama Pharma, especially in hospital and pharmacy channels.
• PT Parit Padang Global: Jakarta-based pharmaceutical distributor in Indonesia supplying ethical and OTC products to hospitals and pharmacies. Direct peer in geography, scale, and product offering to Merapi Utama Pharma.
• Tempo Scan Pacific: Listed Indonesian pharmaceutical manufacturer and distributor with its own distribution arm handling third-party brands. Comparable to Merapi Utama Pharma as a domestic pharma distribution player serving Indonesian institutions and retailers.

Regional players

• Combiphar: Indonesia-focused pharmaceutical company with manufacturing and selected distribution activities. Has overlapping Indonesian pharma distribution footprint with Merapi Utama Pharma though it is more manufacturer-led.

Broad incumbents

• McKesson Corporation: One of the largest global pharmaceutical wholesalers and distributors. Provides a benchmark for scale, technology, and margin profile that Merapi Utama Pharma would be expected to converge toward through PE-driven professionalization.
• Cardinal Health: Global pharmaceutical and medical product distributor with broad logistics capabilities. Useful comparable for what a fully scaled Indonesian pharma distributor could aspire to in terms of product breadth and compliance infrastructure.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/merapi-utama-pharma-pt

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Merapi Utama Pharma